Nexus Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,000
Closed -$462K 75
2024
Q2
$462K Sell
6,000
-406,399
-99% -$29.7M 0.05% 61
2024
Q1
$28.2M Buy
412,399
+2,500
+0.6% +$161K 2.72% 19
2023
Q4
$23.7M Buy
409,899
+625
+0.2% +$33.4K 2.47% 23
2023
Q3
$21.6M Sell
409,274
-2,075
-0.5% -$109K 2.44% 22
2023
Q2
$22.2M Buy
411,349
+3,115
+0.8% +$163K 2.42% 26
2023
Q1
$20.4M Sell
408,234
-2,500
-0.6% -$118K 2.25% 27
2022
Q4
$19M Buy
410,734
+500
+0.1% +$21.7K 2.15% 27
2022
Q3
$15.9M Buy
410,234
+6,100
+2% +$245K 1.98% 26
2022
Q2
$15.1M Buy
404,134
+3,600
+0.9% +$147K 1.73% 29
2022
Q1
$17.7M Buy
400,534
+5,900
+1% +$256K 1.86% 26
2021
Q4
$16.8M Sell
394,634
-9,300
-2% -$391K 1.71% 28
2021
Q3
$17.5M Sell
403,934
-141
-0% -$6.24K 1.89% 27
2021
Q2
$17.3M Buy
404,075
+2,600
+0.6% +$109K 1.79% 27
2021
Q1
$15.5M Buy
401,475
+150
+0% +$5.68K 1.77% 26
2020
Q4
$13.9M Buy
401,325
+49,175
+14% +$1.77M 1.79% 25
2020
Q3
$13.5M Buy
+352,150
New +$13.6M 2.04% 23

Other funds holding BSX

Nexus Investment Management's BSX Position: Q3 2024 in Review

Nexus Investment Management sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 6,000 shares — an estimated $462K sold.

Nexus Investment Management first reported a position in BSX in Q3 2020 and held it in 16 quarters. The position peaked at $28.2M in Q1 2024. 1,396 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Nexus Investment Management reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
  • Nexus Investment Management sold 6,000 Boston Scientific shares in Q3 2024, an estimated $462K.
  • Nexus Investment Management first reported a position in Boston Scientific in Q3 2020 and held it in 16 quarters.
  • Nexus Investment Management's Boston Scientific position peaked at $28.2M in Q1 2024.
  • 1,396 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Nexus Investment Management's 13F filing for Q3 2024, filed 15 Oct 2024.